Free Trial

Altimmune (ALT) News Today

Altimmune logo
$5.48 -0.03 (-0.45%)
As of 11:19 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ALT Latest News

Altimmune, Inc. stock logo
FY2029 EPS Estimate for Altimmune Decreased by Analyst
Altimmune, Inc. (NASDAQ:ALT - Free Report) - HC Wainwright dropped their FY2029 earnings estimates for shares of Altimmune in a report released on Thursday, May 22nd. HC Wainwright analyst P. Trucchio now expects that the company will post earnings per share of $1.22 for the year, down from their
FY2029 EPS Estimates for Altimmune Cut by HC Wainwright
Altimmune, Inc. stock logo
Altimmune (NASDAQ:ALT) Upgraded to Hold at StockNews.com
StockNews.com raised Altimmune from a "sell" rating to a "hold" rating in a research note on Thursday.
Altimmune (NASDAQ:ALT) Raised to "Hold" at Wall Street Zen
13 Best Multibagger Stocks to Invest in Now
Altimmune, Inc. stock logo
Focus Partners Wealth Invests $884,000 in Altimmune, Inc. (NASDAQ:ALT)
Focus Partners Wealth bought a new stake in shares of Altimmune, Inc. (NASDAQ:ALT - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 122,539 shares of the company's stock, valued at approximately
Altimmune, Inc. stock logo
D. E. Shaw & Co. Inc. Has $3.32 Million Holdings in Altimmune, Inc. (NASDAQ:ALT)
D. E. Shaw & Co. Inc. reduced its holdings in Altimmune, Inc. (NASDAQ:ALT - Free Report) by 39.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 459,833 shares of the company's stock after selling 298,
Altimmune, Inc. stock logo
HC Wainwright Has Strong Forecast for Altimmune Q2 Earnings
Altimmune, Inc. (NASDAQ:ALT - Free Report) - Equities researchers at HC Wainwright lifted their Q2 2025 earnings estimates for Altimmune in a research report issued on Thursday, May 15th. HC Wainwright analyst P. Trucchio now expects that the company will post earnings of ($0.33) per share for th
Altimmune, Inc. stock logo
Baird Financial Group Inc. Takes Position in Altimmune, Inc. (NASDAQ:ALT)
Baird Financial Group Inc. bought a new stake in shares of Altimmune, Inc. (NASDAQ:ALT - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 59,440 shares of the company's stock, valued at a
B. Riley Forecasts Altimmune's Q2 Earnings (NASDAQ:ALT)
What is William Blair's Forecast for Altimmune Q2 Earnings?
Altimmune, Inc. stock logo
Altimmune, Inc. (NASDAQ:ALT) Stock Holdings Raised by Ensign Peak Advisors Inc
Ensign Peak Advisors Inc raised its stake in Altimmune, Inc. (NASDAQ:ALT - Free Report) by 39.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 454,981 shares of the company's stock after purchasing an additional 128,204 shares during the period. Ensign Peak Ad
Altimmune, Inc. stock logo
Altimmune, Inc. (NASDAQ:ALT) Shares Purchased by Ameriprise Financial Inc.
Ameriprise Financial Inc. boosted its position in shares of Altimmune, Inc. (NASDAQ:ALT - Free Report) by 35.6% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,254,898 shares of the company's stock after buying an additional 1,378,854 sh
Altimmune (ALT) Receives a Buy from Stifel Nicolaus
Q1 2025 Altimmune Inc Earnings Call
Altimmune, Inc. stock logo
Altimmune, Inc. (NASDAQ:ALT) Given Consensus Rating of "Buy" by Analysts
Altimmune, Inc. (NASDAQ:ALT - Get Free Report) has received an average rating of "Buy" from the seven research firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, five have assigned a buy rating and one has issued a stro
Altimmune, Inc. stock logo
Bellevue Group AG Acquires 81,786 Shares of Altimmune, Inc. (NASDAQ:ALT)
Bellevue Group AG grew its holdings in Altimmune, Inc. (NASDAQ:ALT - Free Report) by 9.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 945,446 shares of the company's stock after acquiring an additional 81,786 share
Altimmune, Inc. stock logo
Marshall Wace LLP Makes New $472,000 Investment in Altimmune, Inc. (NASDAQ:ALT)
Marshall Wace LLP acquired a new stake in Altimmune, Inc. (NASDAQ:ALT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 65,517 shares of the company's stock, valued at approximately $472,000. Marshall Wace LLP owned 0.09% of Altim
Altimmune, Inc. stock logo
Altimmune (ALT) Projected to Post Quarterly Earnings on Thursday
Altimmune (NASDAQ:ALT) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-altimmune-inc-stock/)
Altimmune, Inc. stock logo
Invesco Ltd. Acquires 215,375 Shares of Altimmune, Inc. (NASDAQ:ALT)
Invesco Ltd. increased its stake in Altimmune, Inc. (NASDAQ:ALT - Free Report) by 679.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 247,086 shares of the company's stock after purchasing an additional 21
Altimmune, Inc. stock logo
Wells Fargo & Company MN Purchases 88,209 Shares of Altimmune, Inc. (NASDAQ:ALT)
Wells Fargo & Company MN increased its position in Altimmune, Inc. (NASDAQ:ALT - Free Report) by 69.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 215,538 shares of the company's stock after acquiring an additional 88
Altimmune, Inc. stock logo
Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of "Moderate Buy" from Analysts
Shares of Altimmune, Inc. (NASDAQ:ALT - Get Free Report) have received an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, six have issued
Altimmune, Inc. stock logo
Altimmune, Inc. (NASDAQ:ALT) Shares Sold by Vanguard Group Inc.
Vanguard Group Inc. lessened its holdings in shares of Altimmune, Inc. (NASDAQ:ALT - Free Report) by 11.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,431,612 shares of the company's stock after selling 552,246 shares d
Altimmune's US$42m Market Cap Fall Books Insider Losses
Altimmune management to meet with Piper Sandler
Altimmune, Inc. stock logo
Altimmune (NASDAQ:ALT) Earns "Buy" Rating from HC Wainwright
HC Wainwright restated a "buy" rating and issued a $12.00 target price on shares of Altimmune in a research note on Thursday.
Altimmune, Inc. stock logo
Altimmune, Inc. (NASDAQ:ALT) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Altimmune, Inc. (NASDAQ:ALT - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the nine brokerages that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation, six have assigned a buy recomm
Altimmune, Inc. stock logo
Altimmune (NASDAQ:ALT) Receives "Buy" Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and issued a $12.00 target price on shares of Altimmune in a research report on Tuesday.
Altimmune, Inc. stock logo
William Blair Reaffirms "Market Perform" Rating for Altimmune (NASDAQ:ALT)
William Blair reiterated a "market perform" rating on shares of Altimmune in a research report on Friday.
Altimmune, Inc. stock logo
Altimmune Sees Unusually High Options Volume (NASDAQ:ALT)
Altimmune, Inc. (NASDAQ:ALT - Get Free Report) was the target of unusually large options trading activity on Friday. Investors purchased 25,356 call options on the company. This represents an increase of approximately 199% compared to the typical volume of 8,475 call options.
Get Altimmune News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALT and its competitors with MarketBeat's FREE daily newsletter.

ALT Media Mentions By Week

ALT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALT
News Sentiment

0.75

1.03

Average
Medical
News Sentiment

ALT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALT Articles
This Week

10

7

ALT Articles
Average Week

Get Altimmune News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:ALT) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners